Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1)

Joseph B. Weiss, Jacob Raber

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1)'. Together they form a unique fingerprint.

Medicine & Life Sciences